Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
IPECAD5 — Fifth International Pharmaco-Economic Conference on Alzheimer’s Disease
Authors
Anders Gustavsson
L. Jonsson
H. Fillit
G. Johansson
A. Wimo
B. Winblad
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 5/2010
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-010-0080-3

Other articles of this Issue 5/2010

The journal of nutrition, health & aging 5/2010 Go to the issue

OriginalPaper

Cost-effectiveness of nutrition interventions in nursing home residents: A pilot intervention

OriginalPaper

Perceptions of aging and health behavior: Determinants of a healthy diet in an older German population

OriginalPaper

Skeletal muscle fat infiltration: Impact of age, inactivity, and exercise

OriginalPaper

Undiagnosed malnutrition and nutrition-related problems in geriatric patients

OriginalPaper

Day care at green care farms: A novelway to stimulate dietary intake of community-dwelling older people with dementia?

OriginalPaper

Predicting functional adverse outcomes in hospitalized older patients: A systematic review of screening tools

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits